Supplier
ABBVIE, LDA
AMADORA · PRT
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
8
Total awarded
€2.5m
8 / 8 with a value
Buyers
3
Sectors
1
Group: ABBVIE(inferred)
Reg. 510229050
Contracts this supplier holds that are running out
- €196,011
9 May 2027
estimated - €258,751
9 May 2027
estimated - €91,237
7 Jun 2027
estimated - €395,361
19 Jun 2027
estimated - €427,040
12 Jul 2027
estimated - €670,453
28 Jul 2027
estimated - €381,130
6 Oct 2027
estimated - €47,919
6 Oct 2027
estimated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| D444 - DEXAMETASONA [700 µG IMPL INTRAVÍTREO EMB] | Unidade Local de Saúde Santa Maria, E.P.E. | ABBVIE, LDA | €258,751 | 17 Oct 2026 |
| Lote 2 | Unidade Local de Saúde de São José, EPE | ABBVIE, LDA | €47,919 | 22 Sept 2026 |
| Lote 1 | Unidade Local de Saúde de São José, EPE | ABBVIE, LDA | €381,130 | 22 Sept 2026 |
| E1022 - EPCORITAMAB [48 MG/0.8 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. | ABBVIE, LDA | €91,237 | 19 Sept 2026 |
| E1022 - EPCORITAMAB [48 MG/0.8 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. | ABBVIE, LDA | €395,361 | 19 Sept 2026 |
| F1427 - FOSLEVODOPA + FOSCARBIDOPA [240 + 12 MG/ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. | ABBVIE, LDA | €427,040 | 12 Sept 2026 |
| F1427 - FOSLEVODOPA + FOSCARBIDOPA [240 + 12 MG/ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. | ABBVIE, LDA | €196,011 | 12 Sept 2026 |
| Foslevodopa 240 mg/ml + Foscarbidopa 12 mg/ml sol inj fr 10 ml sc | Unidade Local de Saúde de Coimbra, EPE | ABBVIE, LDA | €670,453 | 7 Sept 2026 |